# EDGAR Filing Document

**Accession Number:** 0001872789
**File Stem:** 0000947871-23-000158
**Filing Date:** 2023-2
**Character Count:** 6254
**Document Hash:** ce10ba0a9d504431d70f7dec4769a127
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000947871-23-000158.hdr.sgml**: 20230213

**ACCESSION NUMBER**: 0000947871-23-000158

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20230209

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20230213

**DATE AS OF CHANGE**: 20230213

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Embecta Corp.
- **CENTRAL INDEX KEY:** 0001872789
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **IRS NUMBER:** 871583942
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41186
- **FILM NUMBER:** 23618561

**BUSINESS ADDRESS:**
- **STREET 1:** 1209 ORANGE STREET
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19801
- **BUSINESS PHONE:** 2018476800

**MAIL ADDRESS:**
- **STREET 1:** 1209 ORANGE STREET
- **CITY:** WILMINGTON
- **STATE:** DE
- **ZIP:** 19801

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Berra Newco, Inc.
- **DATE OF NAME CHANGE:** 20210714

?xml version="1.0" encoding="utf-8"?

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): February 9, 2023**

**EMBECTA CORP.**

**(Exact name of registrant as specified in its charter)**

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Delaware<br> (State or Other Jurisdiction of Incorporation)** | &nbsp;&nbsp;**Delaware<br> (State or Other Jurisdiction of Incorporation)** |
| &nbsp;&nbsp;**001-41186<br> (Commission File Number)** | &nbsp;&nbsp;**87-1583942<br> (IRS Employer <br> Identification No.)** |
| &nbsp;&nbsp;**300 Kimball Drive, Parsippany, New Jersey<br> (Address of principal executive offices)** | &nbsp;&nbsp;**07054<br> (Zip Code)** |
| &nbsp;&nbsp;**Registrant's telephone number, including area code: (201) 847-6880** | &nbsp;&nbsp;**Registrant's telephone number, including area code: (201) 847-6880** |
| &nbsp;&nbsp;**N/A<br> (Former name or former address, if changed since last report)** | &nbsp;&nbsp;**N/A<br> (Former name or former address, if changed since last report)** |

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

---

| | |
|:---|:---|
| &nbsp;&nbsp; **Title of each class** | &nbsp;&nbsp; **Name of each exchange<br> on which registered** |
| &nbsp;&nbsp;**Common Stock, par value $0.01 per share** &nbsp;&nbsp;**EMBC** | &nbsp;&nbsp;**The Nasdaq Stock Market LLC (Nasdaq Global Select Market)** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ◻

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 5.07. Submission of Matters to a Vote of Security Holders.**

Embecta Corp. ("embecta") held its Annual Meeting of Stockholders on February 9, 2023 (the "2023 Annual Meeting"). The final voting results for each of the matters submitted to a vote of stockholders at the 2023 Annual Meeting are as follows:

***Proposal No. 1***: All of the Board of Directors' Class I nominees for director were elected to serve for a term of three years (until the 2026 annual meeting of stockholders), by the votes set forth in the table below.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Nominee** | **For** | **Against** | **Abstain** | **Broker Non-Vote** |
| David J. Albritton | 49432089 | 1323241 | 43344 | 3268452 |
| Carrie L. Anderson | 49429774 | 1327314 | 41586 | 3268452 |
| Christopher R. Reidy | 42481253 | 8269253 | 48168 | 3268452 |

---

***Proposal No. 2****:* The appointment of Ernst & Young LLP as embecta's independent registered public accounting firm for fiscal year 2023 was ratified by the stockholders by the votes set forth in the table below.

---

| | | | |
|:---|:---|:---|:---|
| **For** | **Against** | **Abstain** | **Broker Non-Votes** |
| 53579516 | 415397 | 72213 | N/A |

---

***Proposal No. 3****:* The stockholders approved, on an advisory, non-binding basis, the compensation of embecta's named executive officers by the votes set forth in the table below.

---

| | | | |
|:---|:---|:---|:---|
| **For** | **Against** | **Abstain** | **Broker Non-Votes** |
| 49015194 | 1711764 | 71716 | 3268452 |

---

 ****

***Proposal No. 4***: The stockholders approved, on an advisory, non-binding basis, annual advisory votes on named executive officer compensation by the votes set forth in the table below. Based on the results of this vote, embecta will hold advisory votes on named executive officer compensation on an annual basis.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **1 year** | **2 years** | **3 years** | **Abstain** | **Broker Non-Votes** |
| 50024138 | 46207 | 473013 | 255316 | 3268452 |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Date: February 13, 2023 | **EMBECTA CORP.** | **EMBECTA CORP.** |
|  | By: | /s/ Jeff Mann  |
|  |  | Senior Vice President, General Counsel, Head of Corporate Development and Corporate Secretary |

---